Proactive Investors USA & Canada | Seattle Genetics Develops New Tumor-Shrinking Cancer Treatment AOL News 27) -- A collaboration between a pharmaceutical company and a biotech firm has yielded a new Hodgkin's lymphoma treatment that can shrink tumors by 75 ... Seattle Genetics, Takeda Drug Shrinks Lymphoma Patients' Tumors in Study Drug Therapy Shrinks Hodgkin's Lymphoma Tumors in Clinical Trial Seattle Genetics Scores Win For Smart-Bomb Cancer Drugs |
Monday, September 27, 2010
Seattle Genetics Develops New Tumor-Shrinking Cancer Treatment - AOL News
http://dschingis-khan-bad-oeynhausen.de/speisekarte.html
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment